There is no guideline in Hong Kong regarding respiratory syncytial virus (RSV) immunoprophylaxis for children with heart disease because of a lack of local data on RSV infection. Therefore, this study evaluated the epidemiology and impact of RSV infection on children with heart disease in Hong Kong, with the goal of providing recommendations regarding RSV immunoprophylaxis.
Introduction
Respiratory syncytial virus (RSV) infection poses a heavy disease burden in children worldwide. 1, 2 Haemodynamically significant congenital heart disease (hs-CHD) has been mainly studied and identified as a risk factor for severe RSV infection. 3, 4 National immunoprophylaxis policies for RSV in children have been adopted worldwide. [5] [6] [7] [8] [9] [10] [11] In Hong Kong, under the Paediatric Coordinating Committee of the Hospital Authority, guidelines and government funding for RSV immunoprophylaxis for children with bronchopulmonary dysplasia of prematurity were established in 2012. 12 However, no consensus has been reached regarding guidelines for RSV immunoprophylaxis for children with congenital or acquired heart disease (HD), because the epidemiology and impact of RSV infection on these patients have not been delineated in Hong Kong. [13] [14] [15] [16] It has been suggested that the high morbidity and mortality rates of RSV infection in children with hs-CHD observed during the prepalivizumab era 3 are no longer applicable, owing to advances in healthcare. To widen the scope of the study regarding HD there is a need to conduct an updated local study regarding the epidemiology and impact of RSV infection on children with all types of HD, with the aim of providing evidence-based recommendations for RSV immunoprophylaxis.
Methods

Study design
Hong Kong has a population of 7.48 million, including a paediatric population (aged ≤18 years) of approximately 1.1 million. Over 90% of in-patient service and nearly all tertiary service is provided by the public health system. There are 12 public hospitals providing approximately 1500 acute paediatric beds, of which 45 are paediatric intensive care beds; the total annual discharges and deaths are approximately 88 500. The present study was a multicentre retrospective case-control study of RSV infection in children in four hospitals with large paediatric departments, including 22 paediatric intensive care beds and approximately 630 acute paediatric beds, from 1 January 2013 to 31 December 2015.
Recruitment criteria
Paediatric patients were recruited using the Clinical Data Analysis and Reporting System electronic database of the Hong Kong Hospital Authority. The inclusion criteria were: (1) 
Data collection
Information was collected regarding epidemiologic characteristics, demographics, and clinical information (eg, laboratory and pharmacy data, preexisting co-morbidities, complications, reinfection, and intensive care unit [ICU] and ventilator requirements). Complications were defined as new secondary diagnosis related to RSV infection in a specific episode. Heart disease was defined as the presence of any active HD, including structural defects and cardiomyopathies. Patients who showed complete resolution of HD were considered normal. Diagnosis was confirmed by echocardiography, with or without cardiac catheterisation. Details of HD were retrieved, such as haemodynamic status, need for medication, and need for operation. One designated paediatrician from each hospital verified and retrieved information from the patients' paper records, if needed. The numbers of hospital admissions for acute respiratory infections in the same period were also retrieved from each hospital. Meteorological information was obtained from the electronic database of the Hong Kong Observatory.
Main outcomes
First, the epidemiology of RSV infection and its association with meteorological conditions in the entire cohort was studied. Then patients were excluded if they had significant co-morbidities other than HD, including chronic lung disease, neuromuscular problems, and immunocompromised status, which are expected to increase the severity of RSV infection. [17] [18] [19] Patients with social problems awaiting placement in the hospital causing undue prolonged hospital stay were also excluded. The remaining patients were then divided into heart disease (HD) and control (without any comorbidities) groups to compare the severity of RSV infection. Cardiac patients alone were analysed to identify cardiac predictors of severe outcome from RSV infection (Fig 1) .
Statistical analysis
Statistical analysis was conducted using SPSS (Windows version 23.0; IBM Corp, Armonk [NY], US). Continuous data were tested for normality. There was a large difference in sample size between the HD and control groups; therefore, non-parametric tests were used to compare these groups: the Mann-Whitney U test was used for univariate analysis of continuous data, and the Chi squared test or Fisher's exact test were used for categorical variables, where appropriate. The same statistical analyses were repeated using a smaller control group (1/10 of the original size), which was obtained by generating an age-and sex-matched random sample from the original control group. This repeat analysis yielded similar results, which showed that the statistical tests used were acceptable despite the large discrepancy in sample size. Univariate and multivariate regression analyses were also performed. A backward variable selection method was used for model building. Results were considered statistically significant when P≤0.05.
Results
Epidemiology
There were 3538 RSV-related hospital admissions in the four paediatric departments during the 3-year period, which constituted 11.8% of acute respiratory infection admissions to the four departments and 43% of all RSV admissions to public hospitals in Hong Kong. The age distribution of the admitted patients is shown in Table 1 . The RSV infections primarily affected children aged <5 years: 96.2% in the entire cohort and 97.3% in the HD group. Furthermore, RSV infections were most common in children aged <1 year: 44.6% in the entire cohort and 56.3% in the HD group. There was a mild male sex preponderance in the entire cohort, as well as in the HD group: male-to-female ratios of 1.32 and 1.29). The mortality rates were 0.14% (n=5) in the entire cohort and 0% in the HD group. All patients who died had an underlying chronic illness, such as congenital hereditary muscular dystrophy, spinal muscular atrophy, acute leukaemia, or asthma.
The aggregated monthly trend of RSV infection is shown in Figure 2 . Most infections (87.7% of those in the entire cohort and 91.1% of those in the HD group) occurred during the period from January to September, peaking from March to August (the spring and summer months). With respect to meteorological factors, bivariate correlation analysis of the entire cohort showed that the aggregated monthly RSV incidence had a statistically significant positive correlation with the monthly mean relative humidity (r=0.71, P=0.010) and statistically significant negative correlations with the monthly Patient episodes for study to compare the severity between patients with heart disease and without, 3313 episodes
Patients fulfilled exclusion criteria, 225 episodes
Patients including chronic diseases other than heart disease and patients with social problems such as child abuse waiting for placement in the hospital and thus unduly prolonging their length of stay were excluded so as to remove confounding factors that will affect the outcome of respiratory syncytial virus infection Heart disease group, 112 episodes to identify severity predictors in this group No heart disease group, 3201 episodes mean wind speed (r=-0.80, P=0.002) and monthly mean atmospheric pressure (r=-0.62, P=0.032) [ Table 2 ]. Backward linear regression revealed that only monthly mean wind speed was significantly and independently associated with monthly RSV incidence (B=-31.716, 95% confidence interval [CI]=-48.61 to -14.82; P=0.002).
Impact of respiratory syncytial virus infection on children with heart disease
Overall, 225 episodes were excluded because they involved patients who had co-morbidities other than HD. The HD group had 112 episodes involving 105 patients, while the control group had 3201 episodes involving 3155 patients. The demographic and clinical details of both groups are depicted in Table 4 ).
Predictors of severe outcome in cardiac patients
In the HD group, 26 patients had a history of partial surgical repair of heart lesions, while nine others Abbreviations: NS = not significant; RSV = respiratory syncytial virus * R 2 =0.636 † Meteorological data obtained from Climatological Information Service, Hong Kong Observatory Table 5 ].
Discussion
To the best of our knowledge, this is the first study reviewing the epidemiology and impact of RSV infection on children with HD in Hong Kong. The representative sample in this study included 43% of all RSV-related hospitalisations in the public sector. Respiratory infection due to RSV was common in children in Hong Kong, causing 11.8% of hospital admissions for acute respiratory infection; it was most common in children aged <5 years, similar to the findings of another study in Hong Kong (96.2% vs 98.4%). 13 However, the incidence of respiratory infection due to RSV in patients aged <1 year in the present study was lower than that in Western studies (44.6% vs 75%-90%). 2 This is potentially because babies in Hong Kong are typically cared for at home with the help of grandparents or domestic helpers, rather than attending nursery facilities. Coupled with the small number of children in most Hong Kong families, this may have reduced the rate of cross-infection. 20 Male sex was identified as a risk factor for RSV-related hospitalisation, as in prior studies, but the male preponderance in this study was slightly lower than that of other studies (1.32:1 vs 1.44-1.65:1). 2, 13, [20] [21] [22] [23] The mortality rate of RSVrelated hospitalisation was extremely low (0.14%), which was similar to the rates in local and worldwide studies (0.15%-1%). 2, 13, 15 Most deaths occurred in patients who had underlying chronic illnesses.
Although the seasonality of RSV infection in Hong Kong, a subtropical area, is not well-defined in the manner observed in temperate regions, there is a degree of seasonal variation. As in other studies from Hong Kong and Singapore, [13] [14] [15] [16] 24 this study showed that RSV infection peaked in the humid spring and summer months, but was less common from October to December during the dry and windy season. Indeed, analysis of meteorological data showed that RSV infection was positively correlated with relative humidity and negatively correlated with both wind speed and atmospheric pressure. Relative humidity has been consistently associated with RSV infection rate in other studies. 13, 16, 25 Notably, RSV in large particle aerosol form is more stable at higher humidity and may thus favour transmission. 25 While temperature, rainfall, and sunlight were associated with RSV infection in previous studies, 13, 16, 25 this study showed that wind speed was negatively associated with RSV infection. We presume that strong wind disturbs the stability of RSV in aerosol. We recommend that individuals who care for young children maintain a dry and well-ventilated environment to decrease the likelihood of crossinfection. In addition, this study highlighted the differences in RSV seasonality in Hong Kong, relative to other parts of Asia. Taiwan has two biennial peaks (spring and autumn), while Malaysia has a single peak infection period (September to December). 22, 23 Thus, local epidemiological and climatic data are pivotal in determining the appropriate timing for RSV immunoprophylaxis.
In this study, we included all types of HD, rather than CHD alone; notably, acquired HD, such as cardiomyopathy, can increase vulnerability to RSV infection. 26 The characteristics of RSV infection in cardiac patients have changed. First, the percentage of cardiac patients in this study was lower than that in prior studies (3.2% vs 8%-16.4%). 3, 22, [27] [28] [29] Second, the outcome of RSV infection in this study was less severe than that of prior studies with respect to the requirement of ICU care (11.6% vs 30.4%-63%), requirement of mechanical ventilation (3.6% vs 19%-24%), and rate of mortality (0% vs 2.5%-37%). 3, 22, [27] [28] [29] These differences may be related to the ongoing tendencies for economic and healthcare improvement; they may also be related to good antenatal ultrasound service, termination of pregnancies involving severe CHD, and easy access to medical service in Hong Kong. However, as in other studies, children with HD in Hong Kong exhibit significantly more severe outcomes from RSV infection than do children without co-morbidity. 15, 22, 26, [29] [30] [31] In the present study, myocarditis and Kawasaki disease were complications of RSV infection in the non-cardiac group. These associations have not been extensively reported in prior studies, and further investigation is needed. The lack of these complications in the HD group may be explained by the much smaller sample size in that group (the HD group had 112 episodes involving 105 patients, while the control group had 3201 episodes involving 3155 patients). The rate of co-infection with other respiratory viruses in this study was low compared with that reported in a meta-analysis (4.3% vs ≤50%) 2 ; however, the findings were similar in that dual infection led to a more severe disease course and that rhinovirus was the most common coinfecting agent. Notably, adenovirus was the second most common agent in this study, whereas it was human bocavirus in the meta-analysis; the presence of this virus is not routinely assessed in Hong Kong.
Within the HD group, we identified three severity predictors for RSV infection, namely heart failure requiring medications, pulmonary hypertension, and severe airway abnormalities associated with CHD. The first two have been well described 3, 22, 26, 27 and were included in the American Academy of Pediatrics guideline for RSV prophylaxis 11 ; severe airway abnormality associated with CHD has not been extensively investigated in previous studies of RSV infection. Pulmonary artery sling with tracheal stenosis is not easily identified during prenatal examinations and some affected patients remain undiagnosed for a few months after birth. The disease may first be identified during respiratory infection, such as RSV, and most patients exhibit severe courses of disease. In contrast to the findings of the Taiwanese study, 32 we did not find cyanotic CHD to be a severity predictor. This was potentially because the number of such patients was very small in our series (n=1). Indeed, the number of live births of patients with severe cyanotic CHD is decreasing in Hong Kong due to the high rate of termination of pregnancies involving the disease. The number of surviving patients with severe untreated cyanotic CHD is also small, as they either receive some form of surgical treatment or do not survive early infancy.
Early studies stressed the importance of hygiene and infection control for the prevention of RSV infection. 20 The IMpact-RSV study in the late 1990s led to the approval of palivizumab (a monoclonal antibody) for passive immunisation in the US in 1998 and in Europe in 1999 for children with chronic lung disease or prematurity. 5, 6, 33 In 2003, the use of palivizumab in the US was extended to children with hs-CHD (heart failure, pulmonary hypertension, and cyanotic CHD) who were aged ≤2 years. 7, 34 Comparable national guidelines have been gradually adopted globally, including in Asian countries (Japan in 2006 and Korea in 2009). 8, 9 In temperate regions with a distinct RSV season length of approximately 6 months, the typical palivizumab regimen is monthly intramuscular injection at 15 mg/kg/dose during the RSV season, with a maximum of five doses. However, in subtropical regions without a clear RSV season, monthly injection may be necessary for the entire year, which is costly. In 2011, a study in Taiwan showed that a protocol of six consecutive monthly doses in at-risk children, beginning when the risk was initially detected in the first year of life, was also effective. 10 Currently, the American Academy of Pediatrics limits routine RSV immunoprophylaxis to children who have acyanotic CHD with heart failure or pulmonary hypertension in the first year of life. 11 In the United Kingdom, children who have cyanotic or acyanotic CHD with significant co-morbidities are recommended to receive RSV immunoprophylaxis until age 2 years. 35 In 2017, however, an international steering committee broadened the indications to children with unoperated hs-CHD or symptomatic airway abnormalities who were aged ≤2 years, as well as children with cardiomyopathy requiring treatment who were aged ≤1 year. 36 A Canadian-Italian group questioned whether children with hs-CHD need higher doses of immunoprophylaxis because of their increased inherent risks. 37 Numerous studies have shown the safety and efficacy of RSV immunoprophylaxis and its long-term benefit in children with HD. 6, 30, [38] [39] [40] It is therefore imperative to establish similar guidelines in Hong Kong. In accordance with local experience regarding bronchopulmonary dysplasia in premature babies, 12 an RSV immunoprophylaxis scheme administered monthly for five doses, beginning in the first year of life, should be considered in children with HD who exhibit severity predictors such as heart failure, pulmonary hypertension, and/or severe airway abnormality related to CHD. The optimal timing for immunoprophylaxis may be during the local peak of infection, from March to August.
Limitations of this study
Because this was a retrospective hospital-based study, the incidence of RSV respiratory infection may have been underestimated; however, we presume that only patients with relatively mild disease were potentially omitted. As in all retrospective reviews, this study did not use a pre-defined protocol for management and clinical documentation. This limitation was partially addressed by analysing objective clinical details which are relatively standard and easily retrievable through electronic means. We also collected outpatient follow-up records when necessary to provide additional information regarding co-morbidities. However, instances of re-infection before and after the study period were not assessed due to technical limitations, which is not ideal.
Conclusions
Respiratory syncytial virus infections are common in Hong Kong, and the incidence peaks from March to August; prevalence is greatest in children aged <1 year, and there is a mild male preponderance. Infection is favoured by high relative humidity, low wind speed, and low atmospheric pressure. Heart disease, both congenital and acquired, is a distinct risk factor for severe RSV infection in terms of hospital length of stay, reinfection, complication, respiratory failure, and the requirements for ICU care and mechanical ventilation. In Hong Kong, an RSV immunoprophylaxis scheme administered monthly for five doses, beginning during spring and summer in the first year of life, should be considered in children with HD who exhibit any of the following severity predictors: heart failure, pulmonary hypertension, and severe airway abnormalities associated with CHD.
